PAM
RXII

Panagora Asset Management’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Panagora Asset Management’s Portfolio RXII Stock Details RXII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-67,872
Closed -$115K – 2576
2015
Q2 		$115K Sell
67,872
-101,906
-60% -$173K ﹤0.01% 1910
2015
Q1 		$236K Buy
+169,778
New +$236K ﹤0.01% 1614
2014
Q2 		– Sell
-485
Closed -$1K – 2497
2014
Q1 		$1K Buy
+485
New +$1K ﹤0.01% 2330
2013
Q3 		– Sell
-360,251
Closed -$800K – 2487
2013
Q2 		$800K Buy
+360,251
New +$800K ﹤0.01% 1145

Other funds holding RXII

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $3.03B AUM 104.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return